Journal
CIRCULATION
Volume 123, Issue 13, Pages 1436-1450Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.110.004424
Keywords
anticoagulants; atrial fibrillation; dabigatran etexilate; direct thrombin inhibitor; stroke
Funding
- Astra-Zeneca
- Bayer
- Boehringer-Ingelheim
- Bristol-Myers-Squibb
- Daiichi-Sankyo
- Eli-Lilly
- Glaxo-Smith-Kline
- Johnson Johnson
- Portola
- Sanofi-Aventis